An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

Publisher: John Wiley & Sons Inc

E-ISSN: 1545-5017|65|3|pbc.26887-pbc.26887

ISSN: 1545-5009

Source: PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.3, 2018-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract